Clopidogrel - paediatric investigation plan

clopidogrel
PIPHuman

Key facts

Invented name
  • Clopidogrel BMS
  • Clopidogrel BMS
Active Substance
clopidogrel
Therapeutic area
Cardiovascular diseases
Decision number
P/190/2009
PIP number
Clopidogrel
Pharmaceutical form(s)
  • Age-appropriate oral formulation
  • Film-coated tablet
Condition(s) / indication(s)
Thromboembolic events
Route(s) of administration
Oral use
Contact for public enquiries

Bristol-Myers Squibb Pharma EEIG

E-mail: sylvie.gabriel@sanofi-aventis.com
Country: France
Phone: +33 153774152
Fax: +33 153774133

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Decision date

Decision

Share this page